RhumbLine Advisers’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $79.6K | Buy |
+3,411
| New | +$79.6K | ﹤0.01% | 3592 |
|
2024
Q3 | – | Sell |
-852
| Closed | -$7.91K | – | 4359 |
|
2024
Q2 | $7.91K | Sell |
852
-1,285
| -60% | -$11.9K | ﹤0.01% | 4015 |
|
2024
Q1 | $70K | Buy |
2,137
+88
| +4% | +$2.88K | ﹤0.01% | 3543 |
|
2023
Q4 | $54.8K | Sell |
2,049
-60
| -3% | -$1.6K | ﹤0.01% | 3615 |
|
2023
Q3 | $128K | Sell |
2,109
-20
| -0.9% | -$1.21K | ﹤0.01% | 3376 |
|
2023
Q2 | $217K | Sell |
2,129
-2,171
| -50% | -$221K | ﹤0.01% | 3205 |
|
2023
Q1 | $760K | Buy |
4,300
+234
| +6% | +$41.4K | ﹤0.01% | 2250 |
|
2022
Q4 | $1.57M | Buy |
4,066
+29
| +0.7% | +$11.2K | ﹤0.01% | 1912 |
|
2022
Q3 | $1.36M | Buy |
4,037
+247
| +7% | +$83.2K | ﹤0.01% | 1978 |
|
2022
Q2 | $1.25M | Buy |
3,790
+180
| +5% | +$59.2K | ﹤0.01% | 2036 |
|
2022
Q1 | $1.58M | Buy |
3,610
+2
| +0.1% | +$875 | ﹤0.01% | 1928 |
|
2021
Q4 | $1.58M | Sell |
3,608
-29
| -0.8% | -$12.7K | ﹤0.01% | 2004 |
|
2021
Q3 | $2.02M | Sell |
3,637
-497
| -12% | -$276K | ﹤0.01% | 1903 |
|
2021
Q2 | $2.12M | Buy |
4,134
+2,646
| +178% | +$1.36M | ﹤0.01% | 1923 |
|
2021
Q1 | $1.16M | Sell |
1,488
-96
| -6% | -$75K | ﹤0.01% | 2136 |
|
2020
Q4 | $863K | Buy |
1,584
+60
| +4% | +$32.7K | ﹤0.01% | 2207 |
|
2020
Q3 | $698K | Sell |
1,524
-230
| -13% | -$105K | ﹤0.01% | 2139 |
|
2020
Q2 | $1.08M | Buy |
1,754
+121
| +7% | +$74.5K | ﹤0.01% | 2011 |
|
2020
Q1 | $777K | Sell |
1,633
-66
| -4% | -$31.4K | ﹤0.01% | 1991 |
|
2019
Q4 | $986K | Buy |
1,699
+137
| +9% | +$79.5K | ﹤0.01% | 2094 |
|
2019
Q3 | $1.03M | Buy |
1,562
+145
| +10% | +$95.4K | ﹤0.01% | 2025 |
|
2019
Q2 | $1.1M | Buy |
1,417
+124
| +10% | +$96K | ﹤0.01% | 2023 |
|
2019
Q1 | $913K | Buy |
1,293
+69
| +6% | +$48.7K | ﹤0.01% | 2080 |
|
2018
Q4 | $573K | Buy |
1,224
+444
| +57% | +$208K | ﹤0.01% | 2230 |
|
2018
Q3 | $673K | Buy |
780
+39
| +5% | +$33.7K | ﹤0.01% | 2168 |
|
2018
Q2 | $511K | Buy |
741
+38
| +5% | +$26.2K | ﹤0.01% | 2305 |
|
2018
Q1 | $313K | Sell |
703
-22
| -3% | -$9.8K | ﹤0.01% | 2413 |
|
2017
Q4 | $320K | Sell |
725
-136
| -16% | -$60K | ﹤0.01% | 2439 |
|
2017
Q3 | $424K | Buy |
861
+13
| +2% | +$6.4K | ﹤0.01% | 2393 |
|
2017
Q2 | $470K | Buy |
848
+121
| +17% | +$67.1K | ﹤0.01% | 2335 |
|
2017
Q1 | $481K | Buy |
727
+22
| +3% | +$14.6K | ﹤0.01% | 2269 |
|
2016
Q4 | $236K | Buy |
705
+27
| +4% | +$9.04K | ﹤0.01% | 2605 |
|
2016
Q3 | $204K | Sell |
678
-239
| -26% | -$71.9K | ﹤0.01% | 2669 |
|
2016
Q2 | $159K | Buy |
917
+388
| +73% | +$67.3K | ﹤0.01% | 2823 |
|
2016
Q1 | $118K | Buy |
529
+10
| +2% | +$2.23K | ﹤0.01% | 2867 |
|
2015
Q4 | $315K | Buy |
519
+69
| +15% | +$41.9K | ﹤0.01% | 2550 |
|
2015
Q3 | $232K | Buy |
450
+56
| +14% | +$28.9K | ﹤0.01% | 2701 |
|
2015
Q2 | $172K | Buy |
+394
| New | +$172K | ﹤0.01% | 2932 |
|